We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$39.8M
2
AGN
Allergan plc
AGN
+$27.2M
3
BID
Sotheby's
BID
+$17.1M
4
VSM
Versum Materials, Inc.
VSM
+$16.5M
5
ARRY
Array Biopharma Inc
ARRY
+$15.8M

Top Sells

Rank Stock Value
1
TVPT
Travelport Worldwide Limited
TVPT
+$27.8M
2
ULTI
Ultimate Software Group Inc
ULTI
+$19M
3
CNC icon
Centene
CNC
+$15M
4
LXFT
Luxoft Holding, Inc.
LXFT
+$14.7M
5
NAVG
Navigators Group Inc
NAVG
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JOUT icon
1526
Johnson Outdoors
JOUT
$505M
$4K ﹤0.01%
+50
New +$3.85K
LOCO icon
1527
El Pollo Loco
LOCO
$462M
$4K ﹤0.01%
+331
New +$3.84K
NKTR icon
1528
CALL
Nektar Therapeutics
NKTR
$2.58B
$4K ﹤0.01%
+7
New +$3.51K
PAYS icon
1529
Paysign
PAYS
$698M
$4K ﹤0.01%
300
-5,361
-95% -$51K
PPG icon
1530
PPG Industries
PPG
$26.6B
$4K ﹤0.01%
+33
New +$3.76K
SGMO
1531
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4K ﹤0.01%
363
-425
-54% -$4.52K
TTGT icon
1532
TechTarget
TTGT
$278M
$4K ﹤0.01%
+200
New +$3.74K
TXMD icon
1533
TherapeuticsMD
TXMD
$24M
$4K ﹤0.01%
+32
New +$5.74K
UNFI icon
1534
CALL
United Natural Foods
UNFI
$2.85B
$4K ﹤0.01%
400
-700
-64% -$8.05K
XRX icon
1535
CALL
Xerox
XRX
$425M
$4K ﹤0.01%
100
-1,400
-93% -$46.8K
PGNX
1536
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$4K ﹤0.01%
600
+96
+19% +$463
QADA
1537
DELISTED
QAD Inc.
QADA
$4K ﹤0.01%
100
-319
-76% -$14.2K
FC icon
1538
Franklin Covey
FC
$246M
$3K ﹤0.01%
+100
New +$2.97K
GME icon
1539
PUT
GameStop
GME
$8.6B
$3K ﹤0.01%
+2,400
New +$4.69K
RJET
1540
Republic Airways Holdings
RJET
$1B
$3K ﹤0.01%
20
-700
-97% -$96.5K
PETS icon
1541
CALL
PetMed Express
PETS
$42.3M
$3K ﹤0.01%
200
-100
-33% -$1.97K
RCKT icon
1542
Rocket Pharmaceuticals
RCKT
$394M
$3K ﹤0.01%
204
+46
+29% +$803
SBAC icon
1543
SBA Communications
SBAC
$19.5B
$3K ﹤0.01%
12
-354
-97% -$74.7K
SKX
1544
PUT
DELISTED
Skechers
SKX
$3K ﹤0.01%
+100
New +$3.09K
TEVA icon
1545
Teva Pharmaceuticals
TEVA
$41.2B
$3K ﹤0.01%
364
-16,486
-98% -$199K
VYGR icon
1546
Voyager Therapeutics
VYGR
$198M
$3K ﹤0.01%
119
+44
+59% +$1.01K
WMB icon
1547
Williams Companies
WMB
$86.1B
$3K ﹤0.01%
+104
New +$2.89K
X
1548
PUT
DELISTED
US Steel
X
$3K ﹤0.01%
200
-99,800
-100% -$1.54M
LGTY
1549
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$3K ﹤0.01%
200
-159
-44% -$2.09K
ITCI
1550
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3K ﹤0.01%
+200
New +$2.56K
60 61
62
63 64

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.